$Sanofi(SNY.US)$out of all the TO targets you choose this one? I would have held out a little longer this isn't the lung one you want. when the dust settles you'll see. I still would have tendered 8-9 B for the other one and see if they bite before. if not it's going for dbl digits. ok m shocked you were my favorite even less then 50%. stupid dark horse is in play.
1
Report
AuthPresidentColor8cOP :
it had to be the financing and the bond market skiddishness
Sanofi's acquisition of INBRX-101 is a strategic move to bolster its portfolio in rare diseases and immune-mediated respiratory conditions, aligning with its transition into a pure-play biopharmaceutical company.
$MeiraGTx Holdings(MGTX.US)$most stocks latter got acquired at some point by Sanofi$Sanofi(SNY.US)$in companies where they had invested money in the pipeline or the company. Will slowly accumulate dips in this name Last big buyout was $PRVB for my portfolio where Sanofi had invested dollars before FDA decision
White House calls for adequate production of RSV vaccines emphasizing the importance of access for families. AstraZeneca admits Beyfortus demand surpasses previous standards, highlighting its market importance amid rising U.S. RSV cases.
TennesseeRob : So close to Heroin its almost avoidable